IL17A and metabolic dysfunction-associated steatotic liver disease: Through the release of interleukin 17, lymphocytes may alter the gut microbiota, which both causes and worsens NAFLD (Gomes et al., 2016; Douzandeh-Mobarrez and Kariminik, 2019).